RE: GDR AIMO18 Mar 2023 11:40
billthebank: you say 'Next possibility of a placing. Again IMO more than likely but not yet. News of sales or NICE needs to happen first.'
GDR will run out of money at the end of June or possibly a little later. The CEO told us that it would take time for the company to achieve revenue from sales so I don't they have the luxury of choosing when they do a raise. We know its' going to happen but no idea specifically when. My own opinion now that the sp is already over 40p that they will wait until NICE news and final stamp of approval is released on March 30th and, if they have it and it's positive, release news on FDA pre-submission discussions. Think with that the management would be confident the sp will hit well above 60 or even and then strike. If it gets that high then hopefully they can get a major cash raise out of the way and at about 40p. I think they will need a lot and may end up with as much as 20% dilution BUT that would a) see us all the way through to getting FDA approval and also generating income from numerous countries from sale of AIHL and STILL only have about 110m shares in issue. What's not to like?
I reckon that once this raise is out of the way and we have news of sales contracts starting to land with the NHS and abroad that the sp will be well on its way to £1 and more. Might take until the autumn but that will be well over 100% from where we are now. I'm in and staying in. Too risky to try dodging in and out. I know that a raise is coming but it's now a situation where a raise and some further dilution is a good thing to see the company properly on its way for many years.
Once we get to the point where sales contracts in other countries and full NHS engagement land I think a Takeover is possible. That's situation is really not very far away at all.